Molecular Neurodegeneration (Apr 2023)

Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system

  • Annieck M. Diks,
  • Cristina Teodosio,
  • Bas de Mooij,
  • Rick J. Groenland,
  • Brigitta A. E. Naber,
  • Inge F. de Laat,
  • Sandra A. Vloemans,
  • Susan Rohde,
  • Marien I. de Jonge,
  • Linda Lorenz,
  • Debbie Horsten,
  • Jacques J. M. van Dongen,
  • Magdalena A. Berkowska,
  • Henne Holstege

DOI
https://doi.org/10.1186/s13024-023-00604-9
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Background The rs72824905 single-nucleotide polymorphism in the PLCG2 gene, encoding the p.P522R residue change in Phospholipase C gamma 2 (PLCγ2), associates with protection against several dementia subtypes and with increased likelihood of longevity. Cell lines and animal models indicated that p.P522R is a functional hypermorph. We aimed to confirm this in human circulating peripheral immune cells. Methods We compared effects of p.P522R on immune system function between carriers and non-carriers (aged 59-103y), using in-depth immunophenotyping, functional B-cell and myeloid cell assays, and in vivo SARS-CoV-2 vaccination. Results In line with expectations, p.P522R impacts immune cell function only slightly, but it does so across a wide array of immune cell types. Upon B-cell stimulation, we observed increased PLCγ2 phosphorylation and calcium release, suggesting increased B-cell sensitivity upon antigen recognition. Further, p.P522R-carriers had higher numbers of CD20++CD21-CD24+ naive B cells and IgG1+ memory B cells. In myeloid cells, normalized ROS production was higher upon PLCγ2-dependent stimulation. On classical monocytes, CD33 levels were elevated. Furthermore, carriers expressed lower levels of allergy-related FcεRI on several immune cell subsets. Nevertheless, carriers and non-carriers had similar serological responses to SARS-CoV-2 vaccination. Conclusion The immune system from p.P522R-carriers is slightly more responsive to stimulation than in non-carriers.

Keywords